Viva Biotech (01873) announced interim results
- RevenueRMB10.1bn
- Net profitRMB1.0bn
- Profit attributable to ownersRMB80.1M
- Revenue YoY+21.0%
- Net profit YoY-32.1%
- Depreciation & amortisationHK$2.1bn
- Capital expenditureHK$-1.2bn
- Interest-bearing debtHK$13.3bn
Source Viva Biotech



